🇺🇸 Lipofundin MCT in United States

19 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 19

Most-reported reactions

1. Toxic Epidermal Necrolysis — 4 reports (21.05%)
2. Pruritus — 3 reports (15.79%)
3. Shock — 3 reports (15.79%)
4. Stevens-Johnson Syndrome — 3 reports (15.79%)
5. Blister — 1 report (5.26%)
6. Hypertension — 1 report (5.26%)
7. Lip Ulceration — 1 report (5.26%)
8. Neutropenia — 1 report (5.26%)
9. Pneumonia — 1 report (5.26%)
10. Wrong Technique In Drug Usage Process — 1 report (5.26%)

Source database →

Frequently asked questions

Is Lipofundin MCT approved in United States?

Lipofundin MCT does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Lipofundin MCT in United States?

B. Braun Melsungen AG is the originator. The local marketing authorisation holder may differ — check the official source linked above.